Connection

HASHEM EL-SERAG to Cost-Benefit Analysis

This is a "connection" page, showing publications HASHEM EL-SERAG has written about Cost-Benefit Analysis.
Connection Strength

0.406
  1. Reply: To PMID 24957400. Dig Dis Sci. 2015 Feb; 60(2):587.
    View in: PubMed
    Score: 0.098
  2. Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci. 2014 Dec; 59(12):2913-26.
    View in: PubMed
    Score: 0.094
  3. Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology. 2009 Sep; 137(3):763-5.
    View in: PubMed
    Score: 0.067
  4. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
    View in: PubMed
    Score: 0.042
  5. Surveillance for hepatocellular carcinoma: does it work? Am J Gastroenterol. 2002 Oct; 97(10):2676-7.
    View in: PubMed
    Score: 0.042
  6. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000 Feb 15; 132(4):261-9.
    View in: PubMed
    Score: 0.035
  7. Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin N Am. 1997 Jan; 7(1):165-84.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.